The vaccine is administered percutaneously using a bifurcated needle that is dipped into the vaccine solution; the skin is then pricked several times in the upper arm. The Food and Drug Administration ...
GAITHERSBURG, Md., Aug. 29, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics ...
Children at risk as mpox variant hits Congo displacement camps (Reuters) -Emergent BioSolutions said on Monday it would donate 50,000 doses of its smallpox vaccine to the Democratic Republic of the ...
GAITHERSBURG, Md., Aug. 19, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions (EBS) today announced it is proactively working with the World Health Organization (WHO) and the U.S. government to partner ...
GAITHERSBURG, Md., Sept. 25, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced it has secured approximately $400 million in orders in 2024 and 2025 associated with its ...
Emergent BioSolutions Inc. (NYSE: EBS) today announced it has secured a contract award valued at approximately $54 million USD to deliver CNJ-016® [Vaccinia Immune Globulin Intravenous (Human)] (VIGIV ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results